Vaxart, Inc. (VXRT)
NASDAQ
Market Cap
$153.69M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
361 of 809
Rank in Industry
220 of 445
Largest Insider Buys in Sector
VXRT Stock Price History Chart
VXRT Stock Performance
About Vaxart, Inc.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.
Insider Activity of Vaxart, Inc.
Over the last 12 months, insiders at Vaxart, Inc. have bought $13,578 and sold $0 worth of Vaxart, Inc. stock.
On average, over the past 5 years, insiders at Vaxart, Inc. have bought $649,832 and sold $108.51M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Watson W. Mark (director) — $13,578.
The last purchase of 20,000 shares for transaction amount of $13,578 was made by Watson W. Mark (director) on 2024‑06‑18.
List of Insider Buy and Sell Transactions, Vaxart, Inc.
| 2024-06-18 | Watson W. Mark | director | 20,000 0.01% | $0.68 | $13,578 | +4.23% | ||
| 2022-12-28 | Watson W. Mark | director | 20,000 0.0152% | $0.76 | $15,140 | -1.30% | ||
| 2022-06-22 | Ahmad Fuad | Interim CFO | 5,000 0.0037% | $3.22 | $16,100 | -64.14% | ||
| 2022-01-10 | Sale | Yedid Robert A. | director | 1,500 0.0012% | $6.01 | $9,015 | -42.60% | |
| 2021-11-30 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 3,602 0.003% | $8.00 | $28,816 | -52.20% | |
| 2021-09-10 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 1,801 0.0015% | $9.10 | $16,389 | -45.32% | |
| 2021-08-10 | Sale | Tucker Sean | SVP, Chief Scientific Officer | 10,000 0.0089% | $10.20 | $102,000 | -45.30% | |
| 2021-08-10 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 1,801 0.0016% | $10.00 | $18,010 | -45.30% | |
| 2021-07-19 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 1,800 0.0015% | $8.00 | $14,400 | -29.40% | |
| 2021-06-11 | Sale | Yedid Robert A. | director | 10,000 0.0081% | $8.61 | $86,109 | -24.14% | |
| 2021-06-11 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 1,802 0.0014% | $8.00 | $14,416 | -24.14% | |
| 2021-06-09 | Sale | Echerd Margaret | SVP, Principal Accntng Officer | 47,555 0.0412% | $8.00 | $380,440 | -12.70% | |
| 2021-05-07 | Sale | Latour Wouter | director | 100,000 0.0819% | $7.13 | $712,750 | -6.18% | |
| 2021-05-06 | Sale | Latour Wouter | director | 100,000 0.078% | $6.54 | $653,890 | -2.45% | |
| 2021-03-04 | Sale | Latour Wouter | director | 150,000 0.1327% | $6.04 | $906,450 | +16.22% | |
| 2020-11-23 | Sale | Latour Wouter | director | 333,334 0.2702% | $6.32 | $2.11M | +1.05% | |
| 2020-06-29 | Sale | ARMISTICE CAPITAL, LLC | director | 9.39M 13.9107% | $8.29 | $77.8M | -6.34% | |
| 2020-06-26 | Sale | ARMISTICE CAPITAL, LLC | director | 18.23M 31.5118% | $10.38 | $189.19M | -12.81% | |
| 2020-06-03 | Sale | ARMISTICE CAPITAL, LLC | director | 400,000 0.5415% | $2.77 | $1.11M | +150.91% | |
| 2020-06-02 | Sale | ARMISTICE CAPITAL, LLC | director | 800,000 1.0089% | $2.75 | $2.2M | +135.10% |
Insider Historical Profitability
123.58%
| Watson W. Mark | director | 78125 0.0118% | $0.68 | 2 | 0 | <0.0001% |
| Third Point LLC | other | 6890000 4.0809% | $0.68 | 4 | 1 | <0.0001% |
| Finney Michael J. | director | 452572 0.2681% | $0.68 | 3 | 0 | <0.0001% |
| FAHIM RAAFAT E F | President, CEO and CFO | 373474 0.2212% | $0.68 | 3 | 3 | +50% |
| ARMISTICE CAPITAL, LLC | director | 145523 0.0862% | $0.68 | 9 | 24 | +502.07% |
| Aryeh Jason | director | 131783 0.0781% | $0.68 | 0 | 37 | |
| PLUMB RUSSELL H | CEO & President | 127579 0.0756% | $0.68 | 2 | 0 | <0.0001% |
| PATTI JOSEPH M | CEO | 126128 0.0747% | $0.68 | 6 | 0 | <0.0001% |
| Davis Todd C | director | 120000 0.0711% | $0.68 | 0 | 1 | |
| GURY DAVID J | director | 106400 0.063% | $0.68 | 0 | 11 | |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | 105128 0.0623% | $0.68 | 0 | 9 | |
| Fox James | director | 100614 0.0596% | $0.68 | 2 | 0 | <0.0001% |
| KNOTT DAVID M | 10 percent owner | 69900 0.0414% | $0.68 | 1 | 2 | <0.0001% |
| Hudson Leslie | director | 55759 0.033% | $0.68 | 0 | 1 | |
| Tucker Sean | SVP, Chief Scientific Officer | 43881 0.026% | $0.68 | 1 | 1 | <0.0001% |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | 41050 0.0243% | $0.68 | 0 | 10 | |
| VANLENT ANNE | director | 35000 0.0207% | $0.68 | 1 | 0 | <0.0001% |
| COX GEOFFREY F | director | 25679 0.0152% | $0.68 | 2 | 0 | +74.82% |
| Richard John P | director | 20000 0.0118% | $0.68 | 1 | 0 | +568.57% |
| Siegel Jordan I | Sr. VP Fin. & Admin, CFO Treas | 18157 0.0108% | $0.68 | 0 | 2 | |
| DAVIS PETER B | director | 14630 0.0087% | $0.68 | 2 | 0 | +7.57% |
| EBRIGHT GEORGE W | director | 12325 0.0073% | $0.68 | 0 | 2 | |
| Jooste H Le Roux | Sr. VP, Glbl. Sales & Mktng. | 10000 0.0059% | $0.68 | 1 | 0 | +54.12% |
| NASO ROBERT B | Sr. VP Qual., Reg., Prod. Dev. | 9734 0.0058% | $0.68 | 0 | 1 | |
| COLONNESE MARK P | Chief Financial Officer | 7000 0.0041% | $0.68 | 1 | 0 | +9.38% |
| Ahmad Fuad | Interim CFO | 5000 0.003% | $0.68 | 1 | 0 | <0.0001% |
| MCLAIN THOMAS H | Chairman, CEO and President | 240 0.0001% | $0.68 | 1 | 0 | +35.45% |
| Latour Wouter | director | 0 0% | $0.68 | 1 | 4 | +452.78% |
| Echerd Margaret | SVP, Principal Accntng Officer | 0 0% | $0.68 | 0 | 6 | |
| LYNCH TIMOTHY P | director | 0 0% | $0.68 | 0 | 1 | |
| Yedid Robert A. | director | 0 0% | $0.68 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $20M | 8.7 | 15.38M | New | +$20M | 0.02 | |
| The Vanguard Group | $10.98M | 4.78 | 8.45M | +19.93% | +$1.83M | <0.0001 | |
| Geode Capital Management | $2.85M | 1.24 | 2.19M | +11.87% | +$302,820.11 | <0.0001 | |
| Millennium Management LLC | $2.46M | 1.07 | 1.89M | +956.23% | +$2.22M | <0.01 | |
| BlackRock | $2.31M | 1 | 1.77M | -0.84% | -$19,653.40 | <0.0001 | |
| Goldman Sachs | $1.95M | 0.85 | 1.5M | New | +$1.95M | <0.0001 | |
| Renaissance Technologies | $1.2M | 0.52 | 924,300 | +2,074.82% | +$1.15M | <0.01 | |
| Citadel Advisors LLC | $1M | 0.44 | 769,467 | +54.2% | +$351,584.02 | <0.01 | |
| Qube Research & Technologies | $906,552.00 | 0.39 | 697,348 | +32,840.39% | +$903,799.90 | <0.01 | |
| State Street | $758,869.00 | 0.33 | 583,745 | +25.12% | +$152,360.10 | <0.0001 | |
| Marshall Wace | $693,003.00 | 0.3 | 533,079 | New | +$693,003.00 | <0.01 | |
| Hrt Financial Llc | $688,000.00 | 0.3 | 529,578 | +5,191.02% | +$674,996.83 | <0.01 | |
| Northern Trust | $472,810.00 | 0.21 | 363,700 | +8.85% | +$38,434.50 | <0.0001 | |
| Morgan Stanley | $361,754.00 | 0.16 | 278,271 | -24.84% | -$119,531.66 | <0.0001 | |
| Bank of America | $340,328.00 | 0.15 | 261,791 | +48.74% | +$111,516.50 | <0.0001 | |
| Citigroup | $326,134.00 | 0.14 | 250,872 | New | +$326,130.10 | <0.0001 | |
| IHT Wealth Management | $307,634.00 | 0.13 | 236,623 | -0.4% | -$1,228.60 | 0.01 | |
| Cubist Systematic Strategies | $280,770.00 | 0.12 | 215,977 | -22.19% | -$80,061.77 | <0.01 | |
| Susquehanna International Group | $276,598.00 | 0.12 | 212,768 | +172.29% | +$175,017.45 | <0.0001 | |
| Point72 Asia Singapore Pte Ltd | $270,460.00 | 0.12 | 208,046 | +2,915.16% | +$261,489.99 | 0.03 | |
| Raymond James Financial Services Advisors Inc | $261,323.00 | 0.11 | 201,018 | +2.76% | +$7,018.69 | <0.0001 | |
| Squarepoint Ops LLC | $245,908.00 | 0.11 | 189,160 | +690.64% | +$214,805.50 | <0.01 | |
| D. E. Shaw & Co. | $226,988.00 | 0.1 | 174,606 | +62.02% | +$86,889.48 | <0.0001 | |
| Jump Financial Llc | $215,948.00 | 0.09 | 166,114 | New | +$215,948.00 | <0.01 | |
| Charles Schwab | $199,611.00 | 0.09 | 153,547 | 0% | +$0 | <0.0001 | |
| Jane Street Capital | $176,274.00 | 0.08 | 135,595 | +530.03% | +$148,295.32 | <0.0001 | |
| JPMorgan Chase | $159,342.00 | 0.07 | 122,571 | +27,138% | +$158,757.00 | <0.0001 | |
| Gsa Capital Partners Llp | $143,000.00 | 0.06 | 109,976 | -77.49% | -$492,183.39 | 0.01 | |
| Y Intercept Hong Kong Ltd | $119,295.00 | 0.05 | 91,765 | New | +$119,295.00 | 0.01 | |
| T. Rowe Price | $103,000.00 | 0.04 | 78,500 | 0% | +$0 | <0.0001 | |
| Dimensional Fund Advisors | $101,170.00 | 0.04 | 77,823 | -1.61% | -$1,660.10 | <0.0001 | |
| ExodusPoint Capital Management, LP | $102,000.00 | 0.04 | 78,439 | New | +$102,000.00 | <0.01 | |
| Hbk Sorce Advisory Llc | $97,654.00 | 0.04 | 75,118 | 0% | +$0 | <0.01 | |
| OMERS | $91,520.00 | 0.04 | 70,400 | New | +$91,520.00 | <0.01 | |
| Two Sigma | $84,640.00 | 0.04 | 65,108 | +25.76% | +$17,339.32 | <0.0001 | |
| GOLDEN CAPITAL MANAGEMENT LLC | $79,425.00 | 0.04 | 61,096 | +5.16% | +$3,900.01 | <0.01 | |
| Group One Trading | $78,528.00 | 0.03 | 60,406 | -27.01% | -$29,061.57 | <0.01 | |
| Beacon Capital Management Llc | $66,058.00 | 0.03 | 50,814 | New | +$66,058.00 | 0.01 | |
| Balyasny Asset Management Llc | $63,674.00 | 0.03 | 48,980 | New | +$63,674.00 | <0.0001 | |
| Simplex Trading Llc | $59,000.00 | 0.03 | 45,918 | +7.94% | +$4,341.67 | <0.01 | |
| Brevan Howard Capital Management Lp | $58,323.00 | 0.03 | 44,864 | New | +$58,323.00 | <0.01 | |
| Toroso Investments Llc | $56,484.00 | 0.03 | 43,449 | New | +$56,484.00 | <0.0001 | |
| LMR PARTNERS LLP | $56,005.00 | 0.02 | 43,081 | New | +$56,005.00 | <0.01 | |
| Edmond De Rothschild Holding S A | $53,300.00 | 0.02 | 41,000 | 0% | +$0 | <0.0001 | |
| Steward Partners Investment Advisory LLC | $45,500.00 | 0.02 | 35,000 | +105.88% | +$23,400.00 | <0.01 | |
| Ausdal Financial Partners | $43,178.00 | 0.02 | 33,214 | -0.17% | -$74.10 | 0.01 | |
| Stifel | $42,497.00 | 0.02 | 32,690 | -0.3% | -$130.00 | <0.0001 | |
| Tower Research Capital | $41,392.00 | 0.02 | 31,840 | +117.77% | +$22,384.70 | <0.0001 | |
| Jefferies Financial Group | $36,530.00 | 0.02 | 28,100 | New | +$36,530.00 | <0.01 | |
| Private Portfolio Partners LLC | $35,321.00 | 0.02 | 27,170 | -73.67% | -$98,800.00 | 0.01 |